CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

KYMRKymera Therapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $111.79 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$9.30B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-01 · Mainolfi Nello (Chief Executive Officer) · SELL
  • 2026-10-01 · Mainolfi Nello (Chief Executive Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders298
Shares held108,808,439
Value$10.23B
Percent of shares outstanding130.86%
As of quarter end2026-06-30
RECENT NEWS
  • Kymera Therapeutics CEO Nello Mainolfi sells $3.4 million in stock
  • Kymera Therapeutics presents at Morgan Stanley Global Healthcare Conference
  • BofA raises Kymera Therapeutics price target
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Kymera Therapeutics, Inc. (KYMR) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit